JIM
CLVS

Jupiter Investment Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Jupiter Investment Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-89,959
Closed -$1.23M – 475
2016
Q2 		$1.23M Buy
+89,959
New +$1.31M 0.02% 285

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jupiter Investment Management's CLVS Position: Q3 2016 in Review

Jupiter Investment Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2016, closing a stake of 89,959 shares — an estimated $1.23M sold.

Jupiter Investment Management first reported a position in CLVS in Q2 2016 and held it in 1 quarter. The position peaked at $1.23M in Q2 2016. 163 funds tracked by Wall St. Rank hold CLVS as of Q3 2016.

  • Jupiter Investment Management reported no remaining Clovis Oncology, Inc. position as of Q3 2016 after selling out during the quarter.
  • Jupiter Investment Management sold 89,959 Clovis Oncology, Inc. shares in Q3 2016, an estimated $1.23M.
  • Jupiter Investment Management first reported a position in Clovis Oncology, Inc. in Q2 2016 and held it in 1 quarter.
  • Jupiter Investment Management's Clovis Oncology, Inc. position peaked at $1.23M in Q2 2016.
  • 163 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2016.

Based on Jupiter Investment Management's 13F filing for Q3 2016, filed 28 Oct 2016.